Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) EBT Margin (2022 - 2025)

Historic EBT Margin for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to 858.55%.

  • Lucid Diagnostics' EBT Margin rose 1970000.0% to 858.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 1201.19%, marking a year-over-year decrease of 1313000.0%. This contributed to the annual value of 1047.61% for FY2024, which is 11215000.0% up from last year.
  • According to the latest figures from Q3 2025, Lucid Diagnostics' EBT Margin is 858.55%, which was up 1970000.0% from 369.92% recorded in Q2 2025.
  • Lucid Diagnostics' 5-year EBT Margin high stood at 369.92% for Q2 2025, and its period low was 18880.26% during Q3 2022.
  • Moreover, its 4-year median value for EBT Margin was 1471.06% (2023), whereas its average is 4360.22%.
  • Per our database at Business Quant, Lucid Diagnostics' EBT Margin surged by 170657000bps in 2023 and then plummeted by -21896200bps in 2025.
  • Quarter analysis of 4 years shows Lucid Diagnostics' EBT Margin stood at 13328.57% in 2022, then soared by 92bps to 1041.35% in 2023, then grew by 7bps to 964.16% in 2024, then rose by 11bps to 858.55% in 2025.
  • Its EBT Margin stands at 858.55% for Q3 2025, versus 369.92% for Q2 2025 and 3249.76% for Q1 2025.